TELO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Telomir Pharmaceuticals Inc (TELO) is not a suitable buy for a beginner investor with a long-term strategy at this time. The company's financial performance is weak, with significant declines in net income and EPS. There are no positive trading trends, news catalysts, or influential figure activities to support a bullish sentiment. Additionally, technical indicators are mixed, and there are no proprietary trading signals suggesting a strong buy opportunity.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral at 78.198, and moving averages are converging, which does not confirm a strong trend. Key support and resistance levels suggest limited upside potential in the short term.
NULL identified. No recent news, no significant trading trends, and no influential figure activity.
is also down by -0.55%.
In Q3 2025, the company reported no revenue growth (0% YoY), a significant drop in net income (-81.60% YoY), and a decline in EPS (-85.00% YoY). Gross margin remains at 0%.
No data available for trend analysis or analyst rating changes.
